Hepatocellular apoptosis in mice is associated with early upregulation of mitochondrial glucose metabolism

Apoptosis

Volumn 17, Issue 2, 2012, Pages 143-153

  Gottschalk, Sven ^a,b   Zwingmann, Claudia ^a   Raymond, Valérie Ann ^a   Hohnholt, Michaela C ^a   Chan, Tom S ^a   Bilodeau, Marc ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

Author keywords

Apoptosis; CD95; EGF; Energy metabolism; Fas; Liver; NMR spectroscopy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON 13; CASPASE 3; EPIDERMAL GROWTH FACTOR; FAS ANTIBODY; FAS ANTIGEN; GLUCOSE; GLUTATHIONE; PROTEIN BID; PYRUVATE CARBOXYLASE; PYRUVATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ENERGY; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; GLUCOSE METABOLISM; GLUTATHIONE METABOLISM; LIVER CELL; LIVER INJURY; LIVER METABOLISM; LIVER MITOCHONDRION; LIVER PROTECTION; MALE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; EPIDERMAL GROWTH FACTOR; GLUCOSE; GLUTATHIONE; HEPATOCYTES; MALE; MICE; MICE, INBRED BALB C; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; UP-REGULATION;

MUS;

EID: 84862492892     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0669-y     Document Type: Article

References (63)

1. Jaeschke H, Gujral JS, Bajt ML (2004) Apoptosis and necrosis in liver disease. Liver Int 24(2):85-89 (Pubitemid 38584992)
2. Malhi H, Gores GJ (2008) Cellular and molecular mechanisms of liver injury. Gastroenterology 134(6):1641-1654 (Pubitemid 351615416)
3. Canbay A, Friedman S, Gores GJ (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39(2):273-278 (Pubitemid 38222163)
4. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281(5381):1309-1312 (Pubitemid 28406816)
5. Pradelli LA, Beneteau M, Ricci JE (2010) Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 67(10):1589-1597
6. Dejean LM et al (2010) MAC and Bcl-2 family proteins conspire in a deadly plot. Biochim Biophys Acta 1797(6-7):1231-1238
7. Kushnareva Y, Newmeyer DD (2010) Bioenergetics and cell death. Ann N Y Acad Sci 1201:50-57
8. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481-490 (Pubitemid 36263081)
9. Nieminen AL (2003) Apoptosis and necrosis in health and disease: role of mitochondria. Int Rev Cytol 224:29-55
10. Eguchi Y, Shimizu S, Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57(10):1835-1840 (Pubitemid 27209706)
11. Leist M et al (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185(8):1481-1486 (Pubitemid 27187604)
12. Stridh H et al (1999) Tributyltin-induced apoptosis requires glycolytic adenosine trisphosphate production. Chem Res Toxicol 12(10):874-882 (Pubitemid 29498359)
13. Li P et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4):479-489 (Pubitemid 27508237)
14. Liu X et al (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147-157 (Pubitemid 26256586)
15. Vander Heiden MG et al (1999) Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell 3(2):159-167 (Pubitemid 29292617)
16. Hentze H et al (1999) CD95-Mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology 30(1):177-185 (Pubitemid 29300584)
17. Musallam L et al (2002) Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am J Physiol Gastrointest Liver Physiol 283(3):G709-G718 (Pubitemid 34920361)
18. Ueda S et al (2002) Redox control of cell death. Antioxid Redox Signal 4(3):405-414 (Pubitemid 34753380)
19. Franco R et al (2007) The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113(4-5):234-258
20. Li H et al (2005) High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 54(2):540-545
21. Lin Z et al (2000) GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am J Physiol Endocrinol Metab 278(5):E958-E966 (Pubitemid 30366415)
22. Danial NN et al (2003) BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424(6951):952-956 (Pubitemid 37051687)
23. Vander Heiden MG et al (2001) Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21(17):5899-5912 (Pubitemid 32737807)
24. Conricode KM, Ochs RS (1990) Epidermal growth factor and 12-O-tetradecanoylphorbol 13-acetate stimulate lactate production and the pentose phosphate pathway in freshly isolated rat hepatocytes. J Biol Chem 265(34):20931-20937 (Pubitemid 120014100)
25. Moreno F et al (1989) Effects of epidermal growth factor (urogastrone) on gluconeogenesis, glucose oxidation, and glycogen synthesis in isolated rat hepatocytes. Biochem Cell Biol 67(10):724-729 (Pubitemid 20055750)
26. Quintana I et al (1995) The early stimulation of glycolysis by epidermal growth factor in isolated rat hepatocytes is secondary to the glycogenolytic effect. Biochem J 308(Pt 3):889-894
27. Zwingmann C, Bilodeau M (2006) Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology 43(3):454-463
28. Reed DJ et al (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106(1):55-62 (Pubitemid 11246564)
29. Henke J et al (1996) Combined extraction techniques of tumour cells and lipid/phospholipid assignment by two dimensional NMR spectroscopy. Anticancer Res 16(3B):1417-1427 (Pubitemid 26257811)
30. Kriat M et al (1992) Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed 5(4):179-184
31. 13C-NMR. NMR Biomed 16(6-7):370-399
32. Dolle A (2000) Metabolism of D- and L-[(13)C]alanine in rat liver detected by (1)H and (13)C NMR spectroscopy in vivo and in vitro. NMR Biomed 13(2):72-81
33. Luo X et al (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94(4):481-490 (Pubitemid 28391864)
34. Wang K et al (1996) BID: a novel BH3 domain-only death agonist. Genes Dev 10(22):2859-2869 (Pubitemid 26394246)
35. Hentze H et al (2003) Redox control of hepatic cell death. Toxicol Lett 139(2-3):111-118 (Pubitemid 36298969)
36. Owen OE, Kalhan SC, Hanson RW (2002) The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277(34):30409-30412 (Pubitemid 34970728)
37. Bilodeau M (2003) Liver cell death: update on apoptosis. Can J Gastroenterol 17(8):501-506
38. Kaplowitz N (2000) Cell death at the millennium. Implications for liver diseases. Clin Liver Dis 4(1):1-23
39. Kakinuma C et al (1999) Acute toxicity of an anti-Fas antibody in mice. Toxicol Pathol 27(4):412-420 (Pubitemid 29357619)
40. Ogasawara J et al (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364(6440):806-809 (Pubitemid 23261761)
41. Chang B et al (2003) Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis. Arch Biochem Biophys 411(1):63-72 (Pubitemid 36268780)
42. Chu HC et al (2005) Effects of minocycline on Fas-mediated fulminant hepatitis in mice. Br J Pharmacol 144(2):275-282
43. Jaume M et al (2004) Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 40(5):1136-1143 (Pubitemid 39425569)
44. Ow YP et al (2008) Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9(7):532-542
45. King A, Gottlieb E (2009) Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective. Curr Opin Cell Biol 21(6):885-893
46. Skulachev VP (2006) Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11(4):473-485
47. Coloff JL et al (2011) Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem 286(7):5921-5933
48. Pradelli LA et al (2010) Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 29(11):1641-1652
49. Plas DR, Thompson CB (2002) Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 13(2):75-78
50. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129(7):1261-1274 (Pubitemid 46962095)
51. Datta SR et al (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6(1):41-51
52. Danial NN et al (2008) Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med 14(2):144-153 (Pubitemid 351214557)
53. Moumen A et al (2007) Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. Hepatology 45(5):1210-1217 (Pubitemid 46775784)
54. Lahiry L et al (2010) Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Carcinogenesis 31(2):259-268
55. Senaldi G et al (1998) Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology 27(6):1584-1591 (Pubitemid 28264683)
56. Musallam L et al (2004) EGF mediates protection against Fas-induced apoptosis by depleting and oxidizing intracellular GSH stocks. J Cell Physiol 198(1):62-72 (Pubitemid 38124458)
57. Henson ES, Gibson SB (2006) Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18(12):2089-2097 (Pubitemid 44642342)
58. Yoshimoto K, Nakamura T, Ichihara A (1983) Reciprocal effects of epidermal growth factor on key lipogenic enzymes in primary cultures of adult rat hepatocytes. Induction of glucose-6-phosphate dehydrogenase and suppression of malic enzyme and lipogenesis. J Biol Chem 258(20):12355-12360 (Pubitemid 14231160)
59. Feuers RJ et al (1984) Circadian dependent effect of epidermal growth factor, insulin and glucagon on hepatic pyruvate kinase and malic enzyme of mice. Chronobiol Int 1(4):279-286 (Pubitemid 15121448)
60. Mischoulon D et al (1992) Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes. J Cell Physiol 153(2):288-296
61. Molero C, Benito M, Lorenzo M (1993) Regulation of malic enzyme gene expression by nutrients. hormones, and growth factors in fetal hepatocyte primary cultures. J Cell Physiol 155(1):197-203 (Pubitemid 23109073)
62. Soler C, Soley M (1993) Rapid and delayed effects of epidermal growth factor on gluconeogenesis. Biochem J 294(Pt 3):865-872 (Pubitemid 23286579)
63. Tsao MS, Earp HS, Grisham JW (1986) The effects of epidermal growth factor and the state of confluence on enzymatic activities of cultured rat liver epithelial cells. J Cell Physiol 126(2):167-173 (Pubitemid 16185554)